"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
Descriptor ID |
D001943
|
MeSH Number(s) |
C04.588.180 C17.800.090.500
|
Concept/Terms |
Breast Neoplasms- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
- Tumors, Breast
- Neoplasms, Breast
Breast Carcinoma- Breast Carcinoma
- Breast Carcinomas
- Carcinoma, Breast
- Carcinomas, Breast
Mammary Neoplasms, Human- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
Breast Cancer- Breast Cancer
- Cancer, Breast
- Mammary Cancer
- Cancer, Mammary
- Cancers, Mammary
- Mammary Cancers
- Malignant Neoplasm of Breast
- Breast Malignant Neoplasm
- Breast Malignant Neoplasms
- Malignant Tumor of Breast
- Breast Malignant Tumor
- Breast Malignant Tumors
- Cancer of Breast
- Cancer of the Breast
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 13 | 3 | 16 |
1996 | 14 | 2 | 16 |
1997 | 20 | 4 | 24 |
1998 | 23 | 6 | 29 |
1999 | 18 | 1 | 19 |
2000 | 13 | 7 | 20 |
2001 | 20 | 3 | 23 |
2002 | 13 | 6 | 19 |
2003 | 37 | 9 | 46 |
2004 | 27 | 8 | 35 |
2005 | 58 | 6 | 64 |
2006 | 42 | 9 | 51 |
2007 | 36 | 2 | 38 |
2008 | 38 | 4 | 42 |
2009 | 48 | 10 | 58 |
2010 | 56 | 11 | 67 |
2011 | 56 | 15 | 71 |
2012 | 44 | 10 | 54 |
2013 | 63 | 15 | 78 |
2014 | 58 | 13 | 71 |
2015 | 80 | 8 | 88 |
2016 | 51 | 12 | 63 |
2017 | 54 | 7 | 61 |
2018 | 65 | 4 | 69 |
2019 | 54 | 8 | 62 |
2020 | 57 | 11 | 68 |
2021 | 49 | 5 | 54 |
2022 | 47 | 1 | 48 |
2023 | 45 | 3 | 48 |
2024 | 35 | 3 | 38 |
2025 | 20 | 2 | 22 |
To return to the timeline,
click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer. Clin Cancer Res. 2025 May 01; 31(9):1667-1675.
-
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial. J Natl Cancer Inst. 2025 May 01; 117(5):889-897.
-
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial. Breast Cancer Res Treat. 2025 Jul; 212(1):57-69.
-
Integrating Ambient Ionization Mass Spectrometry Imaging and Spatial Transcriptomics on the Same Cancer Tissues to Identify RNA-Metabolite Correlations. Angew Chem Int Ed Engl. 2025 Jun 10; 64(24):e202502028.
-
Non-adherence of cyclin-dependent kinases 4 and 6 inhibitors reduces overall and progression-free survival in patients with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2025 Jul; 212(1):71-78.
-
Purification and biochemical characterization of mutant ligand binding domain of human estrogen receptor a protein. J Steroid Biochem Mol Biol. 2025 Jul; 251:106763.
-
Lineage Tracing and Single-Cell RNA Sequencing Reveal a Common Transcriptional State in Breast Cancer Tumor-Initiating Cells Characterized by IFN/STAT1 Activity. Cancer Res. 2025 Apr 15; 85(8):1390-1409.
-
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response. JCO Precis Oncol. 2025 Apr; 9:e2400546.
-
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast Cancer. Cancer Discov. 2025 Apr 02; 15(4):818-837.
-
Prediction of breast cancer risk for adolescents and young adults with Hodgkin lymphoma. J Natl Cancer Inst. 2025 Apr 01; 117(4):619-628.